BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IGCS - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://igcs.org
X-WR-CALDESC:Events for IGCS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250925
DTEND;VALUE=DATE:20250927
DTSTAMP:20260625T150533
CREATED:20250725T061156Z
LAST-MODIFIED:20250725T061156Z
UID:71783-1758758400-1758931199@igcs.org
SUMMARY:BIG - Breakthrough In Gynaecologic Oncology
DESCRIPTION:Gynecologic oncology remains a rapidly evolving field\, requiring continuous updates on the latest advancements in diagnosis\, treatment\, and patient management. Malignancies such as ovarian\, cervical\, endometrial\, and vulvar cancers demand a multidisciplinary approach that integrates surgery\, chemotherapy\, radiotherapy\, and emerging targeted therapies. \nThis conference aims to provide a platform for leading experts\, researchers\, and clinicians to discuss cutting-edge innovations in gynecologic oncology. Key topics will include molecular and genetic insights into tumor development\, advances in minimally invasive and robotic surgery\, novel systemic therapies\, immunotherapy applications\, and personalized treatment strategies. Additionally\, the role of artificial intelligence\, biomarkers\, and precision medicine in optimizing patient outcomes will be explored. \nAnother critical aspect is survivorship and quality of life\, as improved therapeutic options lead to longer survival. Addressing long-term side effects\, fertility preservation\, and psychosocial care remains essential in comprehensive cancer management. \nBy fostering scientific exchange and collaboration\, this conference seeks to enhance clinical practice\, bridge gaps between research and application\, and ultimately improve the prognosis and quality of life for patients with gynecologic cancers. \nVenice & virtual\, 25-26 September 2025
URL:https://igcs.org/event/big-breakthrough-in-gynaecologic-oncology/
CATEGORIES:Global Events
ATTACH;FMTTYPE=image/png:https://igcs.org/wp-content/uploads/2025/07/Screenshot-2025-07-25-at-09.06.41-scaled.png
END:VEVENT
END:VCALENDAR